Skip to main content

Effects of Obesity on OSA and Its Treatment

  • Chapter
  • First Online:
Primary Care Sleep Medicine

Abstract

Obesity affects obstructive sleep apnea (OSA) via changes in the anatomy and physiology of respiration. Intermittent hypoxia may play a role between OSA and obesity comorbid diseases such as diabetes mellitus, non-alcoholic steatohepatitis (NASH), and pseudotumor cerebri. Obesity and androgen excess are risk factors for OSA in polycystic ovary syndrome (PCOS). Medical or surgical weight loss can lead to improvements in the severity of OSA; however, cure may not be possible and continuous positive airway pressure (CPAP) may still be required. While CPAP may improve metabolic outcomes, there does not appear to be a clear effect of CPAP on weight loss or change in body composition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ogden CL, et al. (2012). Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief (82):1–8.

    Google Scholar 

  2. Young T, et al. The occurrence of sleep disordered breathing among middle aged adults. N Engl J Med. 1993;328(17):1230–5.

    Article  CAS  PubMed  Google Scholar 

  3. Peppard PE, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284:3015–21.

    Article  CAS  PubMed  Google Scholar 

  4. Pillar G, et al. Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care. 2008;31:303–9.

    Article  Google Scholar 

  5. Schwab RJ, et al. Upper airway and soft tissue anatomy in normal subjects and patients with sleep disordered breathing. Am J Respir Crit Care Med. 1995;152:1673–89.

    Article  CAS  PubMed  Google Scholar 

  6. Stauffer JL, et al. Morphology of the uvula in obstructive sleep apnea. Am Rev Respir Dis. 1999;140:724–8.

    Article  Google Scholar 

  7. Schwab RJ, et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med. 2003;168:522–30.

    Article  PubMed  Google Scholar 

  8. Schwab RJ, et al. Upper airway and soft tissue structural changes induced by CPAP in normal subjects. Am J Respir Crit Care Med. 1996;154:1106–16.

    Article  CAS  PubMed  Google Scholar 

  9. Ryan CM, et al. Pathogenesis of obstructive sleep apnea. J Appl Physiol. 2005;99:2440–50.

    Article  PubMed  Google Scholar 

  10. Smith PL, et al. Upper airway pressure flow-relationships in obstructive sleep apnea. J Appl Physiol. 1988;64:789–95.

    CAS  PubMed  Google Scholar 

  11. Schwartz AR, et al. Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol. 1988;64:535–42.

    CAS  PubMed  Google Scholar 

  12. Watanabe T, et al. Contribution of body habitus and craniofacial characteristics to segmental closing pressures of the passive pharynx in patients with sleep disordered breathing. Am J Respir Crit Care Med. 2002;165:260–5.

    Article  PubMed  Google Scholar 

  13. Mezzanotte WS, et al. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest. 1992;89:1571–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. McGinley BM, et al. Upper airway neuromuscular compensation during sleep is defective in obstructive sleep apnea. J Appl Physiol. 2008;105:197–205.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Schwartz AR, et al. Acute upper airway responses to hypoglossal nerve stimulation during sleep in obstructive sleep apnea. Am J Respir Crit Care Med. 2012;185:420–6.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Carrera M, et al. Patients with obstructive sleep apnea exhibit genioglossus dysfunction that is normalized after treatment with continuous positive airway pressure. Am J Respir Crit Care Med. 1999;159:1960–6.

    Article  CAS  PubMed  Google Scholar 

  17. Kimura H, et al. Differences in the response of genioglossal muscle activity to sustained hypoxia between healthy subjects and patients with obstructive sleep apnea. Respiration. 1994;61:155–60.

    Article  CAS  PubMed  Google Scholar 

  18. Edström L, et al. Neurogenic effects on the palatopharyngeal muscle in patients with obstructive sleep apnoea: a muscle biopsy study. J Neurol Neurosurg Psychiatry. 1992;55:916–20.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Boyd JH, et al. Upper airway muscle inflammation and denervation changes in obstructive sleep apnea. Am J Respir Crit Care Med. 2004;170:541–6.

    Article  PubMed  Google Scholar 

  20. Sharma SK, et al. A stepped approach for prediction of obstructive sleep apnea in overtly asymptomatic obese subjects: a hospital based study. Sleep Med. 2004;5:351–7.

    Article  CAS  PubMed  Google Scholar 

  21. Sergi M, et al. Sleep apnea in moderate-severe obese patients. Sleep Breath. 1999;3:47–52.

    Article  PubMed  Google Scholar 

  22. Schwartz AR, et al. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc. 2008;5:185–92.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Steier J, et al. Neural respiratory drive in obesity. Thorax. 2009;64:719–25.

    Article  CAS  PubMed  Google Scholar 

  24. Khoo MC, et al. Factors inducing periodic breathing in humans: a general model. J Appl Physiol. 1982;53:644–59.

    CAS  PubMed  Google Scholar 

  25. Piper AJ, et al. Big breathing: the complex interaction of obesity, hypoventilation, weight loss and respiratory function. J Appl Physiol. 2010;108:199–205.

    Article  PubMed  Google Scholar 

  26. Tasali E, et al. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 2008;133(2):496–506.

    Article  PubMed  Google Scholar 

  27. Liu A, et al. Habitual shortened sleep and insulin resistance: an independent relationship in obese individuals. Metabolism. 2013;62(11):1553–6.

    Article  PubMed  Google Scholar 

  28. Stamatakis K. Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep. 2008;31:1018–24.

    PubMed Central  PubMed  Google Scholar 

  29. Drager LF, et al. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity. 2011;19:2167–74.

    Article  CAS  PubMed  Google Scholar 

  30. Iiyri N, et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med. 2007;175:851–7.

    Article  Google Scholar 

  31. Xu J, et al. Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress. Free Radic Biol Med. 2009;46:783–90.

    Article  CAS  PubMed  Google Scholar 

  32. Bonsignore MR, et al. Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur Respir J. 2012;39(5):1136–43.

    Article  CAS  PubMed  Google Scholar 

  33. Cizza G, et al. Obstructive sleep apnea is a predictor of abnormal glucose metabolism in chronically sleep deprived obese adults. PLoS One. 2013;8(5):e65400.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Gastaldelli A, et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease and early atherosclerosis in a large European population. Hepatology. 2009;49:1537–44.

    Article  CAS  PubMed  Google Scholar 

  35. Mirrakhimow EA, et al. Obstructive sleep apnea and non-alcoholic fatty liver disease: is the liver another target? Front Neurol. 2012;3:149.

    Google Scholar 

  36. Polotsky VY, et al. Obstructive sleep apnea, insulin resistance and steatohepatitis in severe obesity. Am J Respir Crit Care Med. 2009;179:228–34.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Weingarten TN, et al. Nonalcoholic steatohepatitis in bariatric patients with a diagnosis of obstructive sleep apnea. Obes Facts. 2012;5(4):587–96.

    Article  PubMed  Google Scholar 

  38. Aron-Wisnewsky J, et al. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol. 2012;56(1):225–33.

    Article  CAS  PubMed  Google Scholar 

  39. Kapsimalis F, Kryger MH. Gender and obstructive sleep apnea syndrome, part 2: mechanisms. Sleep. 2002;25(5):499–506.

    PubMed  Google Scholar 

  40. Ehrman D. Metabolic dysfunction in PCOS: relationship to obstructive sleep apnea. Steroids. 2012;77(4):290–4.

    Article  Google Scholar 

  41. Fogel RB, et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86(3):1175–80.

    CAS  PubMed  Google Scholar 

  42. Mokhlesi B, et al. Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women. Fertility & Sterelity. 2012;97(3):786–91.

    Article  Google Scholar 

  43. Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab. 2001;86:517–20.

    CAS  PubMed  Google Scholar 

  44. Purvin VA, et al. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol. 2000;118(12):1626–30.

    Article  CAS  PubMed  Google Scholar 

  45. Sugita Y, et al. Marked episodic elevation of cerebrospinal fluid pressure during nocturnal sleep in patients with sleep apnea hypersomnia syndrome. Electroencephalogr Clin Neurophysiol. 1985;60(3):214–9.

    Article  CAS  PubMed  Google Scholar 

  46. Thurtell MJ, et al. Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population data. J Neurol. 2013;260(7):1748–51.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Mechanick JI, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2013;9(2):159–91.

    Article  PubMed  Google Scholar 

  48. Marceau P, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22:947–54.

    Article  CAS  PubMed  Google Scholar 

  49. Sjöström L, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;2004(351):2683–93.

    Article  Google Scholar 

  50. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273:219–34.

    Article  PubMed  Google Scholar 

  51. Sarkhosh K, et al. The impact of bariatric surgery on obstructive sleep apnea: a systematic review. Obes Surg. 2013;23:414–23.

    Article  PubMed  Google Scholar 

  52. Buchwald H, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;14:1724–37.

    Article  Google Scholar 

  53. Greenburg DL, et al. Effects of surgical weight loss on measure of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122:535–42.

    Article  PubMed  Google Scholar 

  54. Newman AB, et al. Progression and regression of sleep-disordered breathing with changes in weight. Arch Intern Med. 2005;165:2408–13.

    Article  PubMed  Google Scholar 

  55. Dixon JB, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;308:1142–9.

    Article  CAS  PubMed  Google Scholar 

  56. Sjöström L. Analysis of the XENDOS study (Xenical in the prevention of diabetes in obese subjects). Endocr Pract. 2006;12(Suppl):31–3.

    Article  PubMed  Google Scholar 

  57. Svendsen M, et al. Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders. Nutr J. 2011;10:21.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  58. Hollander PA, Elbein SC, Hirsch IB, et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care 1998;21(8):1288–94.

    Article  CAS  PubMed  Google Scholar 

  59. Fidler MC, et al. A one-year trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endorinol Metab. 2011;96:3067–77.

    Article  CAS  Google Scholar 

  60. Allison DB, et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity. 2012;20(2):330–42.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Winslow DH, et al. A randomized, double-blind placebo-controlled study of an oral, extended-release formulation of phentermine/topiramate for the treatment of obstructive sleep apnea in obese adults. Sleep. 2012;35:1529–39.

    PubMed Central  PubMed  Google Scholar 

  62. 2 new drugs for weight loss. Med Lett Drugs Ther 2012; 54: 69–71.

    Google Scholar 

  63. Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med. 2002;346:393–403.

    Article  CAS  PubMed  Google Scholar 

  64. Group DP. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–86.

    Article  Google Scholar 

  65. Tuomilehto HP, et al. Lifestyle intervention with weight reduction. First-line treatment with mild obstructive sleep apnea. Am J Respir Crit Care Med. 2009;179:320–7.

    Article  PubMed  Google Scholar 

  66. Johansson K, Neovius M, Lagerro YT, et al. Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomized controlled trial. BMJ 2009;339:b4609.

    Article  PubMed Central  PubMed  Google Scholar 

  67. Foster GD, Borradaile KE, Sanders MH, et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes. Arch Intern Med 2009;169(17):1619–26.

    Article  PubMed Central  PubMed  Google Scholar 

  68. Awad KM, Malhotra A, Barnet JH, et al. Exercise is associated with a reduced incidence of sleep-disordered breathing. Am J Med 2012;125:485–90.

    Article  PubMed Central  PubMed  Google Scholar 

  69. Kline CE, Crowley EP, Ewing GB, et al. The effect of exercise training on obstructive sleep apnea and sleep quality: a randomized controlled trial. Sleep 2011;34:1631–40.

    PubMed Central  PubMed  Google Scholar 

  70. Peppard PE, Young TY. Exercise and sleep-disordered breathing: an association independent of body habitus. Sleep 2004;27:480–84.

    PubMed  Google Scholar 

  71. Quan S, O’Connor GT, Quan JS, et al. Association of physical activity with sleep-disordered breathing. Sleep Breath 2007;11:149–57.

    Article  PubMed  Google Scholar 

  72. Iftikhar IT, Kline CE, Youngstedt SD. Effects of exercise training on sleep apnea: a meta-analysis. Lung 2014;192:175–84.

    Article  PubMed  Google Scholar 

  73. Sivam S, et al. Effects of 8 weeks of continuous positive airway pressure on abdominal adiposity in obstructive sleep apnoea. Eur Respir J. 2012;40:913–8.

    Article  CAS  PubMed  Google Scholar 

  74. Chin K, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999;100:706–12.

    Article  CAS  PubMed  Google Scholar 

  75. Munzer T, et al. Effects of long-term continuous positive airway pressure on body composition and IGF-1. Eur J Endocrinol. 2010;162(4):695–704.

    Article  CAS  PubMed  Google Scholar 

  76. Garcia JM, et al. Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res. 2011;12(1):80.

    Article  PubMed Central  PubMed  Google Scholar 

  77. Lam JC, et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J. 2010;35(1):138–45.

    Article  CAS  PubMed  Google Scholar 

  78. Iftikhar IH, Khan MF, Das A, et al. Meta-analysis: continuous positive airway pressure improves insulin resistance in patients with sleep apnea without diabetes. Ann Amer Thorac Soc 2013;10:115–20.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shirley F. Jones M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Jones, S.F., Brito, V. (2014). Effects of Obesity on OSA and Its Treatment. In: Pagel, J., Pandi-Perumal, S. (eds) Primary Care Sleep Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1185-1_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1185-1_18

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1184-4

  • Online ISBN: 978-1-4939-1185-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics